Virtual Clinic Introduces Digital Substance Use Treatment Program For Cannabis Use Disorder
Pelago, a digital clinic partner to U.S. businesses and health plans for substance use management, announced Tuesday the addition of cannabis to its specialized substance use disorder (SUD) treatments. The new program, which will be fully implemented by Q3 2024, expands the New York-headquartered digital substance use treatment solutions that currently include support for tobacco, alcohol and opioids.
“We’re at an important inflection point in the U.S., with cannabis use disorders on the rise as treatment simultaneously declines,” stated Pelago CEO and co-founder Yusuf Sherwani, M.D. “This marks an important addition to our dedicated substance use management offering as we work to provide employers and health plans with specialized care for cannabis use and other disorders for improved health outcomes.”
The program launch follows Pelago’s recent $58 million funding round and marks the first large-scale digital cannabis use treatment program in the nation.
Cannabis use disorder (CUD) is a condition often described as the continued use of cannabis despite its negative impact on …